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Abstract
Introduction: The analysis of flow and pressure waveforms generated by ventilators can be useful in the
optimization of patient-ventilator interactions, notably in chronic obstructive pulmonary disease (COPD) patients. To
date, however, a real clinical benefit of this approach has not been proven.
Methods: The aim of the present randomized, multi-centric, controlled study was to compare optimized
ventilation, driven by the analysis of flow and pressure waveforms, to standard ventilation (same physician, same
initial ventilator setting, same time spent at the bedside while the ventilator screen was obscured with numerical
data always available). The primary aim was the rate of pH normalization at two hours, while secondary aims were
changes in PaCO2, respiratory rate and the patient’s tolerance to ventilation (all parameters evaluated at baseline,
30, 120, 360 minutes and 24 hours after the beginning of ventilation). Seventy patients (35 for each group) with
acute exacerbation of COPD were enrolled.
Results: Optimized ventilation led to a more rapid normalization of pH at two hours (51 vs. 26% of patients), to a
significant improvement of the patient’s tolerance to ventilation at two hours, and to a higher decrease of PaCO2
at two and six hours. Optimized ventilation induced physicians to use higher levels of external positive end-
expiratory pressure, more sensitive inspiratory triggers and a faster speed of pressurization.
Conclusions: The analysis of the waveforms generated by ventilators has a significant positive effect on
physiological and patient-centered outcomes during acute exacerbation of COPD. The acquisition of specific skills
in this field should be encouraged.
Trial registration: ClinicalTrials.gov NCT01291303.
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Introduction
Noninvasive positive pressure ventilation (NIV) is to
date the first-line intervention for patients suffering
from acute exacerbation of chronic obstructive pulmon-
ary disease (COPD) and respiratory acidosis, reducing
intubation rate and mortality [1-3]. The failure rate of
NIV (that is, the need for endotracheal intubation or
death) for this collective is up to 25% [1,4-6], a percen-
tage varying significantly according to the timing of NIV
application and the fast response to this treatment [5].
During the most commonly used mode of NIV-Pressure
Support Ventilation (PSV)-the “independent” variables
to be set by the operator (that is, external positive end-
expiratory pressure, PEEPext, level of support, speed of
pressurization, sensitivity of the inspiratory triggering
and expiratory cycling systems) influence the “depen-
dent “ variables (that is, the tidal volume, respiratory
timing and frequency). The setting of the ventilator
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during noninvasive PSV is often complicated since the
altered respiratory mechanics of COPD patients (that is,
the elevated resistances and compliance and intrinsic
positive end-expiratory pressure (PEEPi)), together with
the presence of air leaks, may deeply interfere with the
synchrony between the machine and the patient [7-9].
In intubated patients, a patient/ventilator mismatching
is associated with a poor outcome, and during NIV it
might determine a bad tolerance to NIV and conse-
quently its failure [10].
The close observation of the ventilator graphics (that
is, the flow and pressure waveforms) can be used to
detect a gross patient/ventilator mismatching and indir-
ectly, when the flow does not reach zero at the end of
expiration, to suppose the presence of PEEPi [11]. It has
been suggested, but never directly assessed, that the sys-
tematic use of ventilator signals on the screen may be
useful in depicting these asynchronies and at the same
time in driving the operator in his/her decision to
change the settings [11].
The purpose of this randomized controlled study was
to compare, in patients under NIV for acute exacerba-
tion of COPD, the efficacy of ventilator settings driven
by the analysis of flow and pressure waveforms on the
screen (optimized ventilation) vs. a standard ventilation,
where only numerical data were obtained from the ven-
tilator. The primary aim was the normalization of pH
(that is, ≥ 7.35) at two hours while secondary aims were
the changes in some physiological variables, and the
final outcome at 30 days (that is, NIV success rate vs.
need for endotracheal intubation or death).
Materials and methods
Patients and setting
This multicentric, randomized, prospective, controlled
study involved consecutive patients affected by COPD
exacerbation (defined as an acute change in a patient’s
baseline dyspnoea, cough and/or sputum beyond day-to-
day variability sufficient to warrant a change in therapy
[12]), and respiratory acidosis (that is, pH < 7.35) with
elevated PaCO2 (> 50 mmHg) and hypoxemia (that is,
PaO2 < 60 mmHg) that were treated by NIV in addition
to standard medical therapy. The study was carried out
in five respiratory intermediate intensive care units,
where the personnel was well trained in the use of NIV,
with at least three years’ experience. The study was
approved by the local ethical committees and registered
at ClinicalTrials.gov with the number NCT01291303.
Written informed consent was given by all the patients.
The various units all used full-face masks (UltraMirage,
ResMed, San Diego, CA, USA; FilLife and PerforMax
Respironics, Murryville, PA, USA), and different types of
ventilators (Elysée, ResMed-Saime, North Ryde, NSW,
Australia; Esprit, Respironics, Murryville PA, USA;
Extend, Taëma, Anthony, France; Servo I, Maquet,
Solna, Sweden and Vela, Viasys Healthcare, Palm
Springs, CA, USA), all equipped with a screen showing
flow and pressure waveforms, and with the opportunity
to change both inspiratory and expiratory triggers and
initial flow rate. Patients from both groups were venti-
lated with the same kind of ventilator in every center.
Three centers used a heat and moisture exchanger
(HME), and two centers used heated humidifiers. Exclu-
sion criteria were the need of intubation or the lack of
informed consent. Pre-determined criteria for endotra-
cheal intubation were: 1) cardiac and respiratory arrest;
2) worsening of pH and carbon dioxide tension in arter-
ial blood (PaCO2) in spite of NIV administration (for
example, pH < 0.04 and PaCO2 > 6 mmHg) [5]; 3) the
need to protect the airways; 4) hemodynamic instability
(for example, heart rate < 50 beats/minute with loss of
alertness, and/or systolic blood pressure < 70 mmHg)
[5]; and 5) agitation and inability to tolerate the mask
[12]. NIV failure was defined as the need for endotra-
cheal intubation or death.
Study protocol
At the beginning of the trial the patients were rando-
mized using a computer generated sequence [13] to a
different ventilator setting:
“Optimized ventilation” (screen analysis-driven ventila-
tion): the operator was allowed to watch the flow and
pressure waveforms on the screen in real time and all
the changes in the ventilator settings were performed
accordingly as specified in details below;
“Standard ventilation": the ventilator screen was
obscured with a black paper sheet and only the numeri-
cal data were available.
Patients, all treated with maximal medical therapy
according to international guidelines [12], were venti-
lated in PSV mode, with similar initial settings that
were: PEEPext of 4 cmH2O and pressure support (over
PEEPext) of 12 cm H2O, speed of pressurization as max-
imum tolerated, inspiratory and expiratory trigger of 5
L/minute and 50% of peak inspiratory flow, respectively,
and a FiO2 to reach a SpO2 level of about 94%. In order
to achieve an adequate level of comfort for the patient
at the beginning of the NIV, the attending physician and
one nurse spent at least 20 minutes at the bedside.
The general approach (signs of potential patient-venti-
lator mismatch and action) for the screen analysis dri-
ven ventilation (Optimized ventilation) was as follows
[8,11,14-18]: 1. Sign: individuation of autotriggering.
Action: reduction of air leaks, and/or reduction of
inspiratory trigger sensitivity. 2. Sign: individuation of
ineffective efforts. Action: titration of pressure support,
inspiratory and expiratory triggers, and PEEPext. 3.
Signs of potential late cycling-off (pressure increase at
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the end of inspiratory cycle or flow and pressure pro-
longed plateau). Action: reduction of air leaks and/or
titration of expiratory trigger, or setting of maximal
inspiratory time. 4. Signs of potential early cycling-off
(convex pattern of expiratory flow waveform and con-
cavity of pressure waveform). Action: titration of expira-
tory trigger. 5. Signs of potentially not balanced PEEPi
(expiratory flow that does not reach zero prior to
inspiration or ineffective efforts). Action: titration of
PEEPext.
As a general rule changes in PS were carried out by
steps of 2 cmH2O, and changes in inspiratory and
expiratory triggers by steps of 5 to 10%.
Data collection
The following data were registered for every patient: 1)
general demographic information; 2) clinical data at
baseline and at 30, 120, 360 minutes and 24 hours after
the beginning of NIV: blood gas analysis (not at 30 min-
utes), respiratory rate, tidal volume (Vt) expressed per
Kg of ideal body weight (IBW), patients tolerance to
ventilation, and ventilator settings (PEEPext, level of
pressure support, inspiratory triggering, expiratory
cycling, and the speed of pressurization); and 3) the
final outcome of the treatment at 30 days (NIV success
rate, need for endotracheal intubation, death). The
patients’ tolerance to ventilation was evaluated with an
ad hoc scale, previously validated for five scores: 1) bad;
2) poor; 3) sufficient; 4) good; and 5) very good [19,20].
The patients were asked by the physician to answer the
following question: “How do you feel your breathing is
at this moment?” For each condition tested, the patient
placed a finger on the number that best represented the
intensity of their dyspnoea. Moreover, difficulty in
inspiration and expiration was evaluated by means of a
visual analogue scale (VAS), with a score ranging
between 0 and 10 (10 being the highest inspiratory or
expiratory difficulty).
Statistical analysis
The analyzed data were recorded for all 70 patients,
with the exception of patients’ alarm activations (data
available for 40 patients) and the numbers regarding
inspiratory triggering (data from 50 patients), since the
ventilators used for the remaining patients were
equipped with a qualitative scale for setting the inspira-
tory trigger (ranging from 1 to 5) instead of the absolute
value (L/minute). According to the number of enrolled
patients, a Kolmogorov-Smirnov test was performed
before the data analysis in order to examine the data
distribution of the overall sample. Normally distributed
continuous variables were analyzed with a parametric
test (Student’s t-test), otherwise a nonparametric test
(Wilcoxon-Mann-Whitney test) was used; Fisher’s test
served for categorical data. All data are reported as
mean ± standard deviation (SD), if not otherwise stated.
The present study was powered to detect an improve-
ment (increase of success rate) of pH normalization
(that is, ≥ 7.35) at two hours of 40%. To reach a power
of 80% and a significance level of 0.05 in a two-sided
test, the number of patients to be enrolled resulted in
35 for each treatment arm. P-values < .05 were consid-
ered statistically significant. Data were analyzed using
the Statistical Package for the Social Sciences (version
17.0; SPSS, Chicago, IL, USA).
Results
The baseline features of the two groups were similar
(Table 1).
Primary end point
“Optimized ventilation” when compared to “standard
ventilation” was associated with a higher rate of pH nor-
malization at two hours (51% vs. 26%; P = 0.049; Figure
1a). After that time frame, this rate, even if always
higher in the “optimized ventilation”, was not statisti-
cally different. Figure 1b shows changes in pH values.
While absolute values were not significantly different
among groups, patients treated in “optimized ventila-
tion” showed a faster pH normalization, with a delta pH
(actual data minus baseline values) significantly higher
at two and six hours (P = 0.036 and 0.039, respectively)
when compared with “standard ventilation”.
Secondary endpoints
NIV success rate was similar in the two groups (86%
and 80% for “optimized ventilation” and “standard
Table 1 Baseline characteristics of enrolled patients
Optimized
Ventilation
Standard
ventilation
P
N° 35 35
Age, yrs 76 ± 10 79 ± 7 .173
Men, n (%) 24 (69) 21 (60) .618
BMI, Kg/m2 25.5 ± 6.2 27.0 ± 6.3 .302
BMI > 30, n (%) 7 (20) 8 (23) .771
LTOT, n (%) 25 (71) 20 (57) .318
Domiciliary NIV, n°
(%)
3 (9) 7 (20) .306
Pre-NIV data
Respiratory rate 35 ± 6 33 ± 7 .093
pH 7.27 ± .05 7.28 ± .05 .450
PaO2/FiO2 222 ± 87 226 ± 56 .796
PaCO2, mmHg 76 ± 17 71 ± 12 .141
HCO3
-, mmol/l 33 ± 6 32 ± 7 .569
Data reported as mean ± standard deviation. No significant differences
between groups. BMI, body mass index; LTOT, long-term oxygen therapy; NIV,
noninvasive ventilation.
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ventilation”, respectively, P = 0.752) as well as the over-
all survival rate at 30 days (91% and 89% for “optimized
ventilation” and “standard ventilation”, respectively, P =
1.0).
As shown in Figure 2, PaCO2 decreased significantly
faster until Hour 6 in the “optimized ventilation”, while
changes in respiratory rate and tidal volume were simi-
lar in both groups (Table 2).
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Figure 1 Rate of pH normalization (pH ≥ 7.35) and changes in actual pH values. B. Vertical error bars on data points represent the
standard error of the mean.
Di Marco et al. Critical Care 2011, 15:R283
http://ccforum.com/content/15/6/R283
Page 4 of 9
The application of NIV reduced inspiratory and
expiratory difficulties in both groups; patients in the
“optimized ventilation” group, however, reported a sig-
nificantly higher tolerance to ventilation at two hours,
and less frequently activated the alarm at two and six
hours (Table 3).
At all time points patients treated with the “optimized
ventilation” settings were ventilated with a higher level
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Figure 2 Changes in PaCO2 (actual data minus baseline values). Vertical error bars on data points represent the standard error of the mean.
The values indicate the P of between-group Student’s t-test.
Table 2 Changes of gas exchanges, and respiratory rate during NIV according to treatment
Optimized Ventilation Standard ventilation P
After 30 minutes of NIV
RR, cycles/minute 28 ± 6 26 ± 7 .197
Vt/IBW, ml/Kg 7.8 ± 1.4 7.4 ± 1.8 .316
After 2 hours of NIV
RR, cycles/minute 25 ± 4 24 ± 6 .285
Vt/IBW, ml/Kg 8.0 ± 1.7 7.4 ± 1.8 .260
PaO2/FiO2 220 ± 58 241 ± 49 .119
HCO3
-, mmol/l 33 ± 6 32 ± 7 .537
After 6 hours of NIV
RR, cycles/minute 24 ± 4 24 ± 7 .827
Vt/IBW, ml/Kg 8.0 ± 2.1 7.6 ± 2.1 .395
PaO2/FiO2 235 ± 60 243 ± 37 .506
HCO3
-, mmol/l 33 ± 6 32 ± 7 .534
After 24 hours of NIV
RR, cycles/minute 22 ± 6 22 ± 4 .932
Vt/IBW, ml/Kg 8.1 ± 2.4 7.7 ± 2.1 .545
PaO2/FiO2 235 ± 60 243 ± 37 .713
HCO3
-, mmol/l 35 ± 7 33 ± 6 .404
Data reported as mean ± standard deviation. IBW, ideal body weight; RR, respiratory rate; Vt, tidal volume.
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of PEEPext (P < 0.01 in all comparisons, see Table 4),
without differences for the level of pressure support.
Moreover, patients in “optimized ventilation” were ven-
tilated with a more sensitive inspiratory trigger (at all
time points, except for the beginning of NIV), and with
a faster speed of pressurization until Hour 2 (Table 4).
Discussion
Our study demonstrated that the real time analysis of
pressure and flow waveforms during NIV (optimized ven-
tilation) was associated with a different ventilator setting
(that is, higher level of PEEPext, more sensitive inspira-
tory triggering and faster speed of pressurization) com-
pared to the standard ventilation, leading to a more rapid
pH normalization in patients needing NIV for COPD
exacerbation, with a faster PaCO2 reduction in the first
six hours of ventilation. Even if the NIV success rate was
not affected by this ventilatory approach, these results
appear to be of some clinical relevance, since it was pre-
viously well demonstrated that the outcome of NIV in
patients with acute exacerbation of COPD depends
mainly on the early response to the treatment rather than
to the baseline severity of the respiratory failure [5].
The baseline severity of the enrolled patients (pH
approximately 7.28) reflects the results of a larger
clinical trial [5], with minor interference due to the
study on the “normal clinical practice” (doctors used the
same setting, for example, ventilator, interface and para-
meter of ventilation usually used in their units), with the
only difference due to the obscured screen in the “stan-
dard ventilation” group, suggesting a significant external
validity of the present study. Moreover, this study was
not tailored to detect a difference in terms of NIV suc-
cess, condition needing a larger sample size.
It is currently accepted that staff training and equip-
ment are two important factors affecting NIV success
[21], and that the mechanisms leading to this result can
be numerous; our study suggests that one of these may
be the interaction between the personnel skills and tech-
nology (the possibility of waveforms analysis). In spite of
the recent technological advances, both in the algorithm,
monitoring and in the overall performances of the new
NIV designed ventilators, the experience and the train-
ing of the NIV team remain fundamental to understand
and judge the behavior of a patient undergoing a sup-
ported breathing trial.
Despite several papers that have suggested that the
real-time observation of some biological signals (that is,
flow and pressure) during mechanical ventilation may
be useful in real life, this is the first study (to our
Table 3 Changes in patients’ tolerance to ventilation
All patients Optimized ventilation Standard ventilation P
At the beginning of NIV
Tolerance to ventilation 1.5 ± .7 1.5 ± .7 1.5 ± .6 .928
Inspiratory difficulty 7.2 ± 1.9 7.2 ± 2.2 7.2 ± 1.6 1.000
Expiratory difficulty 7.2 ± 2.0 7.1 ± 1.9 7.3 ± 2.1 .735
After 30 minutes of NIV
Tolerance to ventilation 2.6 ± .9 2.7 ± .8 2.6 ± .9 .663
Inspiratory difficulty 5.4 ± 1.3 5.2 ± 2.2 5.6 ± 2.0 .555
Expiratory difficulty 5.6 ± 2.0 5.3 ± 2.1 5.9 ± 1.8 .304
Pts Alarm activation*, n 2.2 ± 3.1 1.9 ± 1.7 2.5 ± 1.9 .416
After 2 hours of NIV
Tolerance to ventilation 2.3 ± 8 2.6 ± .7 1.9 ± .9 .001
Inspiratory difficulty 4.9 ± 1.9 4.7 ± 1.9 5.0 ± 1.9 .494
Expiratory difficulty 4.8 ± 2.0 4.8 ± 2.0 4.9 ± 2.0 .875
Pts Alarm activation*, n 1.9 ± 2.8 1.0 ± 1.9 3.3 ± 3.2 .004
After 6 hours of NIV
Tolerance to ventilation 3.5 ± .8 3.7 ± .7 3.3 ± .9 .092
Inspiratory difficulty 4.0 ± 2.1 3.7 ± 2.1 4.2 ± 2.2 .442
Expiratory difficulty 3.9 ± 2.1 3.5 ± 2.0 4.4 ± 2.2 .124
Pts Alarm activation*, n 2.3 ± 2.8 1.1 ± 1.8 3.4 ± 3.2 .015
After 24 hours of NIV
Tolerance to ventilation 3.8 ± 1.0 3.8 ± 1.0 3.8 ± 1.0 .921
Inspiratory difficulty 3.1 ± 2.1 3.0 ± 2.2 3.2 ± 2.1 .791
Expiratory difficulty 3.2 ± 2.3 3.1 ± 2.5 3.4 ± 2.1 .657
Pts Alarm activation*, n 2.3 ± 3.0 1.1 ± 1.8 3.4 ± 3.2 .387
Data reported as mean ± standard deviation. Pts, patients. *Data available in 40 patients. Significant differences in bold.
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knowledge) showing a potential clinical effect of the so-
called screen analysis ventilation.
The mechanisms by which “optimized ventilation”
leads to an faster pH normalization in exacerbated
COPD patients treated with NIV can be only specula-
tive, since we did not record the effects of changing the
ventilatory settings on ventilation/perfusion ratio, dead
space or the mechanical properties of the lungs, using,
for example, sophisticated measurements such as the
balloon-catheter technique to get values of esophageal
and gastric pressures, or the electromyogram of the dia-
phragm. We hypothesize, that the observed PaCO2
changes are due to differences in the rate between CO2
production and alveolar ventilation. The higher PEEPext
in the “optimized ventilation” group can lead to less
work in breathing and higher tidal volumes (and prob-
ably higher alveolar ventilation). Although the tidal
volumes were higher with “optimized ventilation” than
with “standard ventilation” (along with stable respiratory
frequencies), this difference was not statistically signifi-
cant. Moreover, we are not able to demonstrate a clear
increase in alveolar ventilation with the former method,
since we did not measure dead space ventilation. We
found significant differences in terms of ventilator set-
tings between the screen driven and standard setting
ventilation, with a mild but statistically significant higher
PEEPext, a more sensitive inspiratory trigger and faster
speed of pressurization in the former group. The differ-
ence recorded in terms of PEEPext was related to the
changes performed by the clinicians and based on the
flow profile, not reaching the zero point at the end of
expiration. As a matter of fact the setting of the expira-
tory pressure is one of the major challenges in the venti-
lation practice, especially during the exacerbation of
COPD where a low PEEPext compared to the measured
level of PEEPi may be associated with the elevated work
Table 4 Changes in ventilator setup
All patients Optimized ventilation Standard ventilation P
At the beginning of NIV
PEEP, cmH2O 5.1 ± 1.4 5.5 ± 1.7 4.7 ± .9 .003
PS, cmH2O 13.6 ± 3.4 14.0 ± 3.7 13.2 ± 3.1 .152
Insp trigger*, L/minute 3.2 ± 2.0 2.3 ± 1.8 4.0 ± 1.7 .002
Expiratory trigger, % 40 ± 9 38 ± 9 42 ± 8 .086
Speed of pressurization 1.8 ± .6 1.7 ± .6 2.0 ± .4 .024
After 30 minutes of NIV
PEEP, cmH2O 5.4 ± 1.3 5.9 ± 1.4 4.9 ± .9 .011
PS, cmH2O 14.3 ± 3.5 14.7 ± 3.7 14.0 ± 3.4 .604
Insp trigger*, L/minute 2.9 ± 2.0 2.0 ± 1.7 3.8 ± 1.8 .001
Expiratory trigger, % 40 ± 12 40 ± 14 40 ± 9 .600
Speed of pressurization 1.6 ± .5 1.4 ± .5 1.7 ± .4 .011
After 2 hours of NIV
PEEP, cmH2O 5.4 ± 1.2 5.9 ± 1.3 4.9 ± .9 .030
PS, cmH2O 14.8 ± 3.9 14.9 ± 4.2 14.7 ± 3.7 .820
Insp trigger*, L/minute 2.9 ± 2.0 1.9 ± 1.7 4.1 ± 1.7 0.001
Expiratory trigger, % 37 ± 12 36 ± 14 38 ± 10 .337
Speed of pressurization 1.4 ± .5 1.3 ± .5 1.6 ± .5 .064
After 6 hours of NIV
PEEP, cmH2O 5.4 ± 1.4 5.8 ± 1.6 5.1 ± 1.0 .015
PS, cmH2O 15.3 ± 4.0 15.5 ± 4.2 15.1 ± 4.0 .925
Insp trigger*, L/minute 3.0 ± 2.0 2.0 ± 1.7 3.9 ± 1.8 .001
Expiratory trigger, % 37 ± 11 36 ± 12 39 ± 10 .143
Speed of pressurization 1.6 ± .5 1.5 ± .6 1.7 ± .5 .134
After 24 hours of NIV
PEEP, cmH2O 5.4 ± 1.5 6.0 ± 1.8 4.9 ± .9 .002
PS, cmH2O 14.8 ± 3.9 15.4 ± 4.2 14.3 ± 3.6 .426
Insp trigger*, L/minute 3.1 ± 1.9 2.4 ± 1.8 4.0 ± 1.8 .009
Expiratory trigger, % 37 ± 11 37 ± 12 37 ± 10 .708
Speed of pressurization 1.7 ± .6 1.5 ± .5 1.9 ± .6 .089
Data reported as mean ± standard deviation. Insp trigger, inspiratory trigger; PEEP, external positive end expiratory pressure; PS, pressure support (over PEEP).
Speed of pressurization: data are reported in a qualitative scale ranging from 0 (faster pressurization) to 5 (slower pressurization). *Data available in 50 patients.
Significant differences in bold.
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of breathing, while on the other side a higher PEEPext
could worsen the hyperinflation. Another evocated
mechanism for a better, early NIV response could be
the optimization of inspiratory and expiratory triggers
and pressurization level, to improve patient-ventilator
interaction and reduce the work of breathing [11], espe-
cially in patients with COPD exacerbation [22]. A better
tolerance and adaptation of patients in the “optimized
ventilation” group may have decreased the CO2 produc-
tion and, hence, decreased PaCO2 and increased pH. A
better patient-ventilator interaction was indirectly con-
firmed by a better tolerance of ventilation at two hours
and a reduced number of patient alarm activation with
“optimized ventilation”. Thus, we may corroborate the
hypothesis that most of the ventilator-patient asynchro-
nies are likely to be detected by an expert evaluation of
pressure and flow waveforms without the need for mon-
itoring the diaphragmatic activity during NIV [16].
Accordingly, an important take-home message in the
era of the tremendous spreading of NIV in every setting
is that this technique should be applied by a team with
great experience in technological skills, such as the cap-
ability of analyzing the waveforms generated by the
ventilator.
A number of potential limits of the present study
deserve discussion. First, we did not evaluate the
patients’ work of breathing and asynchrony; so we can-
not prove that “optimized ventilation” reduces the
work of breathing by an improvement of patient-venti-
lator interaction. The lack of these data might limit
generalization of our results, especially to less experi-
enced ICUs. However, our study, due to the lack of
invasive methods or a complex study protocol, better
reflects the “real clinical practice”, significantly increas-
ing the external validity of the results, as previously
stated. Second, this study was not double-blinded.
Even if the initial setting was pre-defined, we cannot
totally rule out a potential bias in the way ventilation
was set and managed by the investigators or attending
physicians depending on the randomization arm.
Moreover, data about patients’ scores of encephalopa-
thy and the impact of the “curve-driven” titration of
NIV on the time-expenditure of nurses compared to
the conventional setting of the ventilator are not avail-
able. Finally, as shown in Table 1, the rate of domicili-
ary NIV in the “standard ventilation” group was
double when compared with the “optimized ventila-
tion” group, even if this difference was not statistically
significant (P = 0.306). This could have theoretically
affected the results of the present study. However, a
post-hoc subgroup analysis, aimed to compare the
results of patients with and without domiciliary NIV,
did not find any significant difference.
Conclusions
The present study demonstrated that “optimized ventila-
tion”, driven by the analysis of the waveforms generated
by ventilators, may have a positive effect on physiologi-
cal and patient-centered outcomes during acute exacer-
bation of COPD. The acquisition of specific skills in this
field should be encouraged.
Key messages
◆ The setting of the ventilator during noninvasive
pressure support ventilation for COPD patients is
often intricate, since the altered respiratory
mechanics, together with the presence of airleaks,
may deeply interfere with the synchrony between the
machine and the patient. During NIV, patient-venti-
lator mismatching might determine a bad tolerance
to NIV and, consequently, its failure.
◆ The close observation of the ventilator graphics
(that is, flow and pressure waveforms) can be used
to detect a gross patient-ventilator mismatching, and
it has been suggested, but never directly assessed,
that the systematic use of ventilator signals on the
screen may be useful in depicting these asynchronies
and at the same time in driving the operator in his/
her decision to change the settings.
◆ We compared, in patients under NIV for acute
exacerbation of COPD, the efficacy of ventilator set-
tings driven by the analysis of flow and pressure
waveforms on the screen vs. a standard ventilation,
where only numerical data were obtained from the
ventilator.
◆ The analysis of flow and pressure waveforms on
the screen led to a more rapid normalization of pH
(that is, ≥ 7.35) at two hours (51 vs. 26% of patients),
to a significant improvement of patient’s tolerance to
ventilation at two hours, and to a higher decrease of
PaCO2 at two and six hours. Moreover, the analysis
of flow and pressure waveforms on the screen
induced physicians to use higher levels of external
positive end-expiratory pressure, more sensitive
inspiratory triggers and a faster speed of
pressurization.
◆ This is the first study showing a potential clinical
effect of screen analysis ventilation. NIV should be
applied by a team with a great deal of experience in
technological skills, such as the capability of analyz-
ing the waveforms generated by ventilator.
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